Topic Hub
8 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 8 of 8 clinical reviews.
A clinical review of finasteride's FDA approval history, current compounding legal status, official label warnings, and post-market safety surveillance data.
Read clinical reviewA detailed comparison of how the FDA and EMA regulate finasteride, covering approval timelines, label warnings, post-market surveillance, and what the divergence means for prescribers and patients.
Read clinical reviewA clinical review of finasteride safety signals in the FDA Adverse Event Reporting System (FAERS), including sexual dysfunction, depression, and suicidality reports that prompted label revisions.
Read clinical reviewA complete regulatory timeline of finasteride's FDA approval history, covering Proscar (1992), Propecia (1997), generic entry, label changes, and current safety requirements.
Read clinical reviewA comprehensive review of finasteride's regulatory approvals worldwide, including FDA history, EMA authorization, label updates, post-market safety signals, and current prescribing requirements across major markets.
Read clinical reviewA complete breakdown of every FDA label change to finasteride (Propecia, Proscar) from 2020 through 2026, including post-market safety signals, prescriber obligations, and what the updated warnings mean for patients on TRT or hair-loss therapy.
Read clinical reviewA comprehensive review of finasteride's FDA approval timeline, patent disputes, generic entry, label evolution, post-market safety signals, and ongoing litigation, with primary-source citations throughout.
Read clinical reviewA full regulatory history of finasteride, including FDA approval dates, Black Box label changes, post-market surveillance findings, and next-generation 5-ARI alternatives in development.
Read clinical review